Identification of a new peptide recognized by autologous cytolytic Tlymphocytes on a human melanoma

Cancer Immunity

Volumn 5, Issue , 2002, Pages 1-10

  Vigneron, Nathalie ^a,b   Ooms, Annie ^a   Morel, Sandra ^b   Degiovanni, Gérard ^a   Van Den Eynde, Benoît J ^b,c  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

Author keywords

Cultured tumor cells; Cytotoxic T lymphocytes; HLA B44; Human; Melanoma; Peptide

Indexed keywords

HLA B ANTIGEN; MELANOMA ANTIGEN; MUTANT PROTEIN; PROTEIN OS 9; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CHROMOSOME 12; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA; MELANOMA CELL; NUCLEIC ACID BASE SUBSTITUTION; POINT MUTATION; PROTEIN ANALYSIS; WILD TYPE;

EID: 3242677994     PISSN: 14249634     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Van den Eynde B, van der Bruggen P. Peptide database of T-cell defined tumor antigens. URL: http://www.cancerimmunity.org/peptidedatabase/ Tcellepitopes.htm
2. De Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora J-P, De Smet C, Brasseur F, van der Bruggen P, Lethé B, Lurquin C, Brasseur R, Chomez P, De Backer O, Cavenee W, Boon T. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 1994; 40: 360-9. (PMID: 7927540)
3. Brichard V, Van Pel A, Wolfel T, Wolfel C, De Plaen E, Lethe B, Coulie P, Boon T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1993; 178: 489-95. (PMID: 8340755)
4. Ikeda H, Lethe B, Lehmann F, van Baren N, Baurain JF, de Smet C, Chambost H, Vitale M, Moretta A, Boon T, Coulie PG. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 1997; 6: 199-208. (PMID: 9047241)
5. Fisk B, Blevins TL, Wharton JT, Ioannides CG. Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines. J Exp Med 1995; 181: 2109-17. (PMID: 7539040)
6. Wolfel T, Hauer M, Schneider J, Serrano M, Wolfel C, Klehmann-Hieb E, De Plaen E, Hankeln T, Meyer zum Buschenfelde KH, Beach D. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 1995; 269: 1281-4. (PMID: 7652577)
7. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P. Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 1997; 275: 1790-2. (PMID: 9065403)
8. Mandruzzato S, Brasseur F, Andry G, Boon T, van der Bruggen P. A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. J Exp Med 1997; 186: 785-93. (PMID: 9271594)
9. Morel S, Ooms A, Van Pel A, Wolfel T, Brichard VG, van der Bruggen P, Van den Eynde BJ, Degiovanni G. A tyrosinase peptide presented by HLA-B35 is recognized on a human melanoma by autologous cytotoxic T lymphocytes. Int J Cancer 1999; 83: 755-9. (PMID: 10597191)
10. Degiovanni G, Lahaye T, Herin M, Hainaut P, Boon T. Antigenic heterogeneity of a human melanoma tumor detected by autologous CTL clones. Eur J Immunol 1988; 18: 671-6. (PMID: 2967757)
11. Su YA, Hutter CM, Trent JM, Meltzer PS. Complete sequence analysis of a gene (OS-9) ubiquitously expressed in human tissues and amplified in sarcomas. Mol Carcinog 1996; 15: 270-5. (PMID: 8634085)
12. Rammensee HG, Friede T, Stevanoviic S. MHC ligands and peptide motifs: first listing. Immunogenetics 1995; 41: 178-228. (PMID: 7890324)
13. Srivastava M, Fleming PJ, Pollard HB, Burns AL. Cloning and sequencing of the human nucleolin cDNA. FEBS Lett 1989; 250: 99-105. (PMID: 2737305)
14. Erard MS, Belenguer P, Caizergues-Ferrer M, Pantaloni A, Amalric F. A major nucleolar protein, nucleolin, induces chromatin decondensation by binding to histone H1. Eur J Biochem 1988; 175: 525-30. (PMID: 3409881)
15. 2+-dependent interaction of N-copine, a member of the two C2 domain protein family, with OS-9, the product of a gene frequently amplified in osteosarcoma. FEBS Lett 1999; 453: 77-80. (PMID: 10403379)
16. Nalefski EA, Falke JJ. The C2 domain calcium-binding motif: structural and functional diversity. Protein Sci 1996; 5: 2375-90. (PMID: 8976547)
17. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Ponten J. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991; 88: 10124-8. (PMID: 1946433)
18. Boon T, Van Snick J, Van Pel A, Uyttenhove C, Marchand M. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis. J Exp Med 1980; 152: 1184-93. (PMID: 6776227)
19. Seed B, Aruffo A. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc Natl Acad Sci USA 1987; 84: 3365-9. (PMID: 2437578)
20. Traversari C, van der Bruggen P, Van den Eynde B, Hainaut P, Lemoine C, Ohta N, Old L, Boon T. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics 1992; 35: 145-52. (PMID: 1537606)
21. Graham FL, van der Eb AJ. Transformation of rat cells by DNA of human adenovirus 5. Virology 1973; 54: 536-9. (PMID: 4737663)